Andrew Saik's Net Worth
$3.35 Million
Who is Andrew Saik?
Andrew Saik has an estimated net worth of $3.35 Million. This is based on reported shares across multiple companies, which include INTERCEPT PHARMACEUTICALS, INC., Menlo Therapeutics Inc., Edge Therapeutics, Inc., AUXILIUM PHARMACEUTICALS INC, ARVINAS, INC., and Milestone Pharmaceuticals Inc..
SEC CIK
Andrew Saik's CIK is 0001616284
Past Insider Trading and Trends
2018 was Andrew Saik's most active year for acquiring shares with 3 total transactions. Andrew Saik's most active month to acquire stocks was the month of May. 2023 was Andrew Saik's most active year for disposing of shares, totalling 8 transactions. Andrew Saik's most active month to dispose stocks was the month of October. 2020 saw Andrew Saik paying a total of $49,920.00 for 38,400 shares, this is the most they've acquired in one year. In 2015 Andrew Saik cashed out on 175,000 shares for a total of $6,392,750.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INTERCEPT PHARMACEUTICALS, INC. (ICPT) No price found
EVP & Chief Financial OfficerAndrew Saik used to own units in Common Stock but no longer holds any shares there. From 2021 to 2023 Andrew Saik acquired a total of 77,156 shares in INTERCEPT PHARMACEUTICALS, INC., Andrew also disposed a total of 77,156 shares of INTERCEPT PHARMACEUTICALS, INC. equalling to $1,410,287.29.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -68.27K |
$19.00 | -$1,297,035.00 |
0
|
Nov 8
| |||
Form 4
| -1.31% | -908.00 |
$10.80 | -$9,806.40 | 68.27K |
Sep 21
| |||
Form 4
| -1.30% | -908.00 |
$11.74 | -$10,659.92 | 69.17K |
Jun 21
| |||
Form 4
| -1.28% | -909.00 |
$14.19 | -$12,898.71 | 70.08K |
Mar 21
| |||
Form 4
| +26.11% | 14.7K |
—
|
—
| 70.99K |
Jan 27
| |||
Form 4
| -1.26% | -718.00 |
$12.37 | -$8,881.66 | 56.29K |
Dec 31
| |||
Form 4
| -1.57% | -908.00 |
$13.43 | -$12,194.44 | 57.01K |
Dec 21
| |||
Form 4
| -1.54% | -908.00 |
$14.85 | -$13,483.80 | 57.92K |
Sep 21
| |||
Form 4
| -5.82% | -3.63K |
$12.48 | -$45,327.36 | 58.82K |
Jun 21
| |||
Form 4
| +19.75% | 10.3K |
—
|
—
| 62.46K |
Jan 27
| |||
Form 4
|
∞
| 52.16K |
—
|
—
| 52.16K |
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Menlo Therapeutics Inc. (VYNE) Snapshot price: $1.87
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Edge Therapeutics, Inc. (PDSB) Snapshot price: $2.91
Chief Financial OfficerAndrew Saik owns 42,549 units of Common Stock which is worth $123,817.59. In the year 2017 Andrew Saik filed a total of 8 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +925.52% | 38.4K |
$1.30 | $49,920.00 | 42.55K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
∞
| 83K |
—
|
—
| 83K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AUXILIUM PHARMACEUTICALS INC No price found
CFOAndrew Saik used to own units in Common Stock but no longer holds any shares there. In the year 2014 Andrew Saik acquired a total of 10,000 shares in AUXILIUM PHARMACEUTICALS INC, Andrew also disposed a total of 10,000 shares of AUXILIUM PHARMACEUTICALS INC equalling to $365,300.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -10.00K |
$36.53 | -$365,300.00 |
0
|
Jan 29
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Aug 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARVINAS, INC. (ARVN) Snapshot price: $24.4
Chief Financial OfficerAndrew Saik owns 61,409 units of Common Stock which is worth $1,498,379.60. In the year 2024 Andrew Saik filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 61.41K |
—
|
—
| 61.41K |
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||